Studies have demonstrated that PRMT1 expression is upregulated in TNBC and contributes to tumor progression and chemotherapy resistance.[20] Metabric and TCGA databases also indicated that PRMT1 expression is upregulated in breast cancer, especially in TNBC (Figure S4A–C, Supporting Information). Here, PRMT1 is linked to breast carcinoma.